TCC-DISSODissociation-Focused Cognitive Behavior Therapy for Dissociative Disorders
CBT-CD psychotherapy
Mental Disorders
+ Dissociative Disorders
Treatment Study
Summary
Study start date: May 16, 2025
Actual date on which the first participant was enrolled.This study aims to determine how effective a specific type of therapy called Dissociation-Focused Cognitive Behavioral Therapy (DF-CBT) is for people experiencing dissociative symptoms and disorders. These symptoms are common among individuals with psychiatric disorders, but there is currently no proven effective treatment. DF-CBT is promising and based on a well-supported scientific model, which makes it an exciting area to explore. Finding an effective treatment could greatly improve the quality of life for many people dealing with these symptoms. Participants in this study will receive DF-CBT, which is a type of therapy focused specifically on addressing dissociative symptoms. The study will evaluate how well this therapy works by observing changes in symptoms over time. This approach does not involve medication but rather focuses on therapeutic techniques. The study does not list specific outcomes being measured, but it generally seeks to identify improvements in the participants' symptoms. Understanding the effectiveness of this therapy can help guide future treatment strategies for dissociative disorders.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.140 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 8 locations
Centre Régional du Psychotraumatisme CRP / CHRU TOURS
Tours, FranceOpen Centre Régional du Psychotraumatisme CRP / CHRU TOURS in Google MapsClinique Psychiatrique Universitaire / CHRU de Tours
Tours, FrancePsychiatrie / CHU ANGERS
Angers, FranceCentre régional du Psychotraumatisme des Hauts de France / CHU LILLE
Lille, France